Aigen Investment Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,708
Closed -$1M 762
2025
Q3
$1M Buy
17,708
+11,683
+194% +$599K 0.16% 196
2025
Q2
$300K Buy
+6,025
New +$272K 0.04% 530
2024
Q2
Sell
-13,059
Closed -$202K 881
2024
Q1
$202K Buy
+13,059
New +$147K 0.04% 542
2023
Q4
Sell
-209,086
Closed -$1.32M 906
2023
Q3
$1.32M Buy
209,086
+40,654
+24% +$302K 0.25% 100
2023
Q2
$1.58M Buy
+168,432
New +$1.67M 0.23% 120
2022
Q1
Sell
-52,686
Closed -$317K 770
2021
Q4
$317K Buy
+52,686
New +$381K 0.02% 778

Other funds holding HIMS

Aigen Investment Management's HIMS Position: Q4 2025 in Review

Aigen Investment Management sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 17,708 shares — an estimated $1M sold.

Aigen Investment Management first reported a position in HIMS in Q4 2021 and held it in 6 quarters. The position peaked at $1.58M in Q2 2023. 485 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

  • Aigen Investment Management reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 17,708 Hims & Hers Health shares in Q4 2025, an estimated $1M.
  • Aigen Investment Management first reported a position in Hims & Hers Health in Q4 2021 and held it in 6 quarters.
  • Aigen Investment Management's Hims & Hers Health position peaked at $1.58M in Q2 2023.
  • 485 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.